drugset / Trial / NCT00901368
FACTO Study (Foster® As Complete Treatment Option)
RandomizedParallel-groupDouble-blindTreatment
Summary
Double blind, multinational, multicentre, randomised, 2 arm parallel group study
Timeline
- Start
- 2009-05
- Primary completion
- 2010-09
- Completion
- 2010-12
Publications
- Results Barnes N, van Noord JA, Brindicci C, Lindemann L, Varoli G, Perpina M, Guastalla D, Casula D, Patel S, Chanez P; FACTO (Foster(R) As Complete Treatment Option) Study Group. Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination. Pulm Pharmacol Ther. 2013 Oct;26(5):555-61. doi: 10.1016/j.pupt.2013.01.011. Epub 2013 Mar 22.
- Oba Y, Anwer S, Maduke T, Patel T, Dias S. Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2022 Dec 6;12(12):CD013799. doi: 10.1002/14651858.CD013799.pub2.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | 500 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 24 ug | Inhaled |
| Subject | Salmeterol | Other / unclassified | 100 ug | Inhaled |
| Subject | beclomethasone dipropionate | Other / unclassified | 400 ug | Inhaled |